Different from IGF2BP2 and IGF2BP3, although the oncogenic roles of YTHDC2 and RBM15 have been identified in colon cancer (60) and acute megakaryoblastic leukemia (61–63), their functions in breast cancer await to be identified. Here, RBM15 is linked to breast carcinoma.